Douglas E. Brough
Corporate Officer/Principal at PRECIGEN, INC.
Douglas E. Brough active positions
| Companies | Position | Start | End |
|---|---|---|---|
| PRECIGEN, INC. | Corporate Officer/Principal | - | - |
| Chief Tech/Sci/R&D Officer | - | - |
Career history of Douglas E. Brough
Former positions of Douglas E. Brough
| Companies | Position | Start | End |
|---|---|---|---|
| GENVEC INC | Chief Tech/Sci/R&D Officer | 2013-08-31 | 2017-06-15 |
Training of Douglas E. Brough
| Purdue University | Undergraduate Degree |
| Idaho State University | Graduate Degree |
| Rutgers State University of New Jersey | Doctorate Degree |
| Robert Wood Johnson Medical School | Doctorate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 2 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 5 |
| Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PRECIGEN, INC. | Health Technology |
| Private companies | 1 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- Douglas E. Brough
- Experience
